Get the Stockscreener App
23.19
1.32%
-0.31
Surrozen Inc stock is traded at $23.19, with a volume of 148.75K.
It is down -1.32% in the last 24 hours and up +6.52% over the past month.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).
See More
Previous Close:
$23.50
Open:
$23.45
24h Volume:
148.75K
Relative Volume:
1.12
Market Cap:
$269.24M
Revenue:
$7.49M
Net Income/Loss:
$-360.50M
P/E Ratio:
-0.5612
EPS:
-41.3227
Net Cash Flow:
$-33.68M
1W Performance:
-6.94%
1M Performance:
+6.52%
6M Performance:
+25.42%
1Y Performance:
+170.60%
1-Day Range:
$21.72
$23.48
1-Week Range:
$21.65
$25.30
52-Week Range:
$8.2001
$35.00
Surrozen Inc Stock (SRZN) Company Profile
Name
Surrozen Inc
Sector
Industry
Phone
650-475-2820
Address
171 OYSTER POINT BLVD, SOUTH SAN FRANCISCO
Compare SRZN vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SRZN
Surrozen Inc
|
23.19 | 269.24M | 7.49M | -360.50M | -33.68M | -41.32 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
Surrozen Inc Stock (SRZN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-21-26 | Initiated | TD Cowen | Buy |
| Feb-19-26 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-30-25 | Initiated | H.C. Wainwright | Buy |
| Jan-03-25 | Upgrade | Guggenheim | Neutral → Buy |
| Oct-11-21 | Initiated | BofA Securities | Buy |
| Sep-15-21 | Initiated | Guggenheim | Buy |
| Sep-07-21 | Initiated | Stifel | Buy |
View All
Surrozen Inc Stock (SRZN) Latest News
Understanding Momentum Shifts in (SRZN) - Stock Traders Daily
Surrozen Inc Warrant 2026-01.08.31 on Surrozen Financial Disclosures & SEC Filings - TradingView
Price to sales forward of Surrozen, Inc. – NASDAQ:SRZN - TradingView
Price to book forward of Surrozen, Inc. – NASDAQ:SRZN - TradingView
Surrozen Inc. (SRZN) Holds Steady Near $25.79 as Biotech Sector Waits for CatalystHigh Reward Trades - dars.gov.et
Avoiding Lag: Real-Time Signals in (SRZN) Movement - Stock Traders Daily
Surrozen, Inc.(NasdaqCM: SRZN) added to Russell 2000 Index - marketscreener.com
Surrozen, Inc.(NasdaqCM: SRZN) added to Russell 2500 Growth Benchmark - marketscreener.com
Surrozen, Inc.(NasdaqCM: SRZN) dropped from Russell Microcap Value Benchmark Index - marketscreener.com
Surrozen, Inc.(NasdaqCM: SRZN) added to Russell 2000 Growth Benchmark - marketscreener.com
Surrozen, Inc.(NasdaqCM: SRZN) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com
Surrozen, Inc.(NasdaqCM: SRZN) added to Russell 3000 Index - marketscreener.com
Surrozen Inc Actuals & Estimates (NASDAQ:SRZN) - TradingView
SRZN Forecast — Price Target — Prediction for 2027 - TradingView
Price to book forward of Surrozen, Inc. – NASDAQ:SRZNW - TradingView
Enterprise value to EBIT forward of Surrozen, Inc. – NASDAQ:SRZNW - TradingView
Enterprise value to EBITDA forward of Surrozen, Inc. – NASDAQ:SRZNW - TradingView
Price to earnings forward of Surrozen, Inc. – NASDAQ:SRZNW - TradingView
Merck Swipes At Surrozen's IP Over Tissue Regrowth Proteins - Law360
Surrozen Inc (SRZNW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Surrozen Inc (SRZN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Surrozen Inc (SRZN) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Discipline and Rules-Based Execution in SRZN Response - Stock Traders Daily
Surrozen Inc (SRZN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Surrozen (SRZN) Dips Over 3% as Stock Tests Key Support LevelsMA Crossover - dars.gov.et
Surrozen Inc (SRZN) Valuation: PE, PB & Fair Value Analysis - TradingKey
Surrozen Inc (SRZN) Institutional Confidence - TradingKey
Surrozen Inc (SRZNW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Surrozen Inc (SRZNW) Institutional Confidence - TradingKey
Surrozen Inc (SRZNW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Surrozen Inc (SRZNW) Valuation: PE, PB & Fair Value Analysis - TradingKey
Surrozen Inc (SRZNW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Surrozen Inc (SRZN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Surrozen Inc (SRZNW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Surrozen Inc (SRZNW) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Surrozen Inc (SRZNW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
SRZN Q1 2026 Earnings: Massive EPS Miss Amid No RevenueEarnings Per Share - newsline.com
Surrozen Inc (SRZN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Surrozen Inc (SRZN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Surrozen Inc (SRZN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Surrozen (SRZN) CFO acquires 607 shares through 2021 employee stock purchase plan - Stock Titan
Surrozen (SRZN) EVP Li Yang gets 1,666 ESPP shares, now holds 18,882 - Stock Titan
Surrozen (SRZN) COO adds 1,666 shares through 2021 employee stock purchase plan - Stock Titan
Surrozen (SRZN) CEO awarded 1,622 ESPP shares at $8.11, now holds 18,175 - Stock Titan
SRZN Q1 2026 Earnings: Significant EPS Miss Reflects Operational ChallengesPeak Earnings Alert - newsline.com
Surrozen Inc. (SRZN) Q1 2026 Earnings: Significant EPS Miss Amidst Operational UpdatesEarnings Whisper Number - newsline.com
Surrozen Warrants (SRZNW) Hold Steady at $0.02 Amidst Minimal MovementCovered Call ETF - newsline.com
SRZN Q1 2026 Earnings: Significant EPS Miss Amid Sharp Stock RallyGeographic Revenue Trends - newsline.com
Surrozen Warrant (SRZNW) Holds at $0.02 as Trading Action Remains MutedUnusual Call Volume - newsline.com
Surrozen Inc. Warrant (SRZNW) Stabilizes at $0.02 Amid Minimal Trading ActivityPrice Surge Stocks - newsline.com
Surrozen Inc. Warrant (SRZNW): Price Stability at $0.02 Amid Minimal TradingNaked POC - newsline.com
Surrozen Inc Stock (SRZN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Surrozen Inc Stock (SRZN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Williams Charles O | Chief Operating Officer |
May 04 '26 |
Sale |
33.33 |
2,036 |
67,866 |
16,571 |
| Parker Craig C | Chief Executive Officer |
May 04 '26 |
Sale |
33.33 |
4,524 |
150,798 |
16,553 |
| TCG Crossover GP II, LLC | 10% Owner |
Mar 24 '26 |
Buy |
24.69 |
106,658 |
2,633,717 |
736,554 |
| TCG Crossover GP II, LLC | 10% Owner |
Mar 23 '26 |
Buy |
24.90 |
15,223 |
379,051 |
683,225 |
| TCG Crossover GP II, LLC | 10% Owner |
Mar 13 '26 |
Buy |
24.88 |
35,433 |
881,463 |
675,018 |
| TCG Crossover GP II, LLC | 10% Owner |
Mar 12 '26 |
Buy |
24.99 |
12,374 |
309,166 |
657,301 |
| TCG Crossover GP II, LLC | 10% Owner |
Mar 16 '26 |
Buy |
24.99 |
1,190 |
29,733 |
675,613 |
| TCG Crossover GP II, LLC | 10% Owner |
Feb 11 '26 |
Buy |
23.57 |
17,763 |
418,763 |
650,567 |
| TCG Crossover GP II, LLC | 10% Owner |
Feb 12 '26 |
Buy |
23.86 |
1,093 |
26,082 |
651,114 |
| TCG Crossover GP II, LLC | 10% Owner |
Feb 03 '26 |
Buy |
21.94 |
4,355 |
95,549 |
641,685 |
2.64%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):